சிோ தலைமை ர்ட் அதிகாரி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Published: Mar 01, 2021
By Heather McKenzie
February 28 marked Rare Disease Day, and biotech companies gathered together to raise awareness, advocate for improved access to treatment and let patients know how they are pivoting to improve patient care and access during the COVID-19 pandemic and beyond. 
Rezolute Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for patients with metabolic and orphan diseases, was just beginning a Phase IIb study of its lead candidate, RZ358, for Congenital hyperinsulinism (HI), when the chaos struck.
“We have hospitals around the world where the COVID ward was right next to the research ward. We had hospitals that for six months shut down entirely,” shared Erin O’Boyle, Head of Clinical Operations at Rezolute. “We had a lot of overnight stays, but then, right when we were kicking off the study and going into enrollment and starting to activate our sites, COVID hit, and it really kind ....

Michele Rhee , Paula Ragan , Tay Sachs Sandhoff , Erin Oboyle , Gavin Corcoran , Patient Affairs , Rezolute Inc , Rare Disease , Rare Disease Day , Erino Boyle , Clinical Operations , Gene Therapies , Sio Chief Rd Officer , Chief Executive Officer , Vice President , Pivots During Pandemic Bring Patient Centric Options To Rare Disease Patients , மைக்கேல் ரீ , பால ராகன் , கவின் கோர்கோரன் , நோயாளி வாழ்க்கைத்தொழில்கள் , ரேர் நோய் , ரேர் நோய் நாள் , மருத்துவ செயல்பாடுகள் , கீந் சிகிச்சைகள் , சிோ தலைமை ர்ட் அதிகாரி , தலைமை நிர்வாகி அதிகாரி ,